Articles

Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study

The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3RS) has awarded its annual prize to a project exploring the use of stem cells for treating glaucoma and other eye diseases.

A laser-based surgical device has been shown during trials to provide a safe, non-penetrating method of reducing intraocular pressure (IOP), according to study results published by the developer of the device, IOPtima Ltd.

Piggyback intraocular lens implant to correct severe refractive error after penetrating keratoplasty in pseudophakes

HIV-1-mediated delivery of a short hairpin RNA targeting vascular endothelial growth factor in human retinal pigment epithelium cells

Posterior lamellar keratoplasty? comparison of deep lamellar endothelial keratoplasty and Descemet stripping automated endothelial keratoplasty in the same patients: a patient's perspective

A single intravitreal injection of 4.0 mg vascular endothelial growth factor (VEGF) Trap-Eye is associated with bioactivity against diabetic macular oedema (DME), according to study results published in the January issue of the British Journal of Ophthalmology.

Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular age-related macular degeneration

The TrueField Analyser, a glaucoma testing device, has been hailed by reseachers at the Australian National University as offering faster, more comprehensive and more accurate diagnoses than current methods.

Various imaging devices fail to identify localized retinal nerve fibre layer (RNFL) defects, according to a study published in the January issue of the British Journal of Ophthalmology.

Treatment of chronic ocular hypotony with intraocular application of sodium hyaluronate

Efficacy of intravitreal and periocular triamcinolone associated with photodynamic therapy for treatment of retinal angiomatous proliferation

CORM-3, a water-soluble carbon monoxide-releasing molecule, is associated with a intraocular pressure (IOP) lowering in animal models of ocular hypertension, concluded a study published in the January issue of the British Journal of Ophthalmology.

Deep sclerectomy with MMC is safer and more effective than trabeculectomy or tube surgery, according to Dr Nitin Anand.

Jay Dermott discusses complications that can ensue during microkeratome and femtosecond flap creation and considers how to apply lessons in clinical practice.

The Phase II RADICAL study (Reduced Fluence Visudyne Anti-VEGF-Dexamethasone In Combination for AMD Lesions) is to continue as planned, following promising interim results and the positive recommendations of the independent Data and Safety Monitoring Committee.

This month's topic: professional expenditure

The concentration of vascular endothelial growth factor (VEGF) in the vitreous is associated with the mean thickness of the fovea as measured by optical coherence tomography (OCT), according to study results published online ahead of print by Investigative Ophthalmology & Visual Science.

Performing LASIK surgery that is customized for each eye can offer more pleasing outcomes in terms of both patient safety and comfort, claims Kerry K. Assil, MD.

Professor Michael Knorz discusses his experiments on the adhesion strength of flaps, comparing the femtosecond with the microkeratome.

Professor Günther Grabner, MD compares Carl Zeiss Meditec's new XL Stabi ZO with its spherical equivalent, the XL Stabi Sky.

Azarga (brinzolamide 10 mg/ml and timolol 5 mg/ml fixed combination) has been approved by the European Medicines Agency (EMEA) for decreasing intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension after failure of monotherapy.

Dr Maeve O'Doherty discusses the literature review she conducted to determine best practice in the treatment of diabetic macular oedema.

Trabeculectomy with MMC and Ex-PRESS shunt device placement appears to be safer than other treatment methods, according to Dr Leon Herndon.

2009 has started with a bang...

The National Neurovision Research Institute (NNRI) in the US and Adeona Pharmaceuticals Inc. have announced a collaboration to investigate the oral drug flupirtine in the treatment of retinitis pigmentosa (RP).

Dr Richard Kaiser outlines the recommendations of the microsurgical safety task force.

Abbott acquires AMO, Alcon gains new CEO…

Professor Scott Cousins explains how we can use our knowledge of drusen formation to find new ways to combat dry age-related macular degeneration.

Investigation of the association between 677C>T and 1298A>C 5,10-methylenetetra- hydrofolate reductase gene polymorphisms and normal-tension glaucoma